Udhayvir Grewal, GI Oncologist at Winship Cancer Institute of Emory University, shared a post on X about a recent article he and his colleagues co-authored, adding:
“On the heels of GI26, happy to share this tour de force led by Suriya Baskar– ‘Precision Oncology Promise in the Management of Pancreatic Acinar Cell Carcinoma’ in EJC PACC is rare (<2% of pancreatic cancers) and biologically distinct from PDAC.
Emerging data show real promise for precision oncology- PARP inhibitors, ICIs, and targeted therapies in genomically selected cases. Broad molecular and germline testing should be standard to improve outcomes in this underserved disease.”
Title: Precision oncology promise in the management of pancreatic acinar cell carcinoma
Authors: Suriya Baskar, Rishi R. Patel, Matthew T. Gao, Brandon E. Rose, Sawyer Bawek, Deepak Vadehra, Timothy J. Brown, Nicholas J. Hornstein, Udhayvir S. Grewal
Read the Full Article on European Journal of Cancer
More posts featuring Udhayvir Grewal.